Buy Giftinat Gefitinib 250mg Tablet Online – GlobMedIndia Saudi Arabia - Riyadh, Jeddah, Mecca, Medina, Dammam, USA, UK, UAE Australia, Europe, United Kingdom, United States, Cambridge, London, Morocco, Indonesia, Chile, Peru, Ethiopia, Romania, China, Japan, Russia, Ukraine, Dubai, United Arab Emirates, South Korea, Africa, Thailand, Vietnam, Middle East, and Southeast Asian countries. - GLOB MED INDIA PHARMA EXPORTER,South Africa

Giftinat Gefitinib 250mg Tablet

Introduction

Giftinat Gefitinib 250mg Tablet is an oral anti-cancer medicine used primarily in the treatment of non-small cell lung cancer (NSCLC). It belongs to the class of targeted therapy drugs known as tyrosine kinase inhibitors (TKIs) that specifically target cancer cell growth pathways.

Manufactured in India, Giftinat is widely used due to its effectiveness and affordability compared to global brands.

Composition & Content

Active Ingredient: Gefitinib 250 mg
Drug Class: Epidermal Growth Factor Receptor (EGFR) inhibitor
Form: Oral tablet

Gefitinib works by blocking the EGFR protein, which promotes cancer cell growth, thereby slowing or stopping tumor progression.

How It Works (Mechanism of Action)

Giftinat targets and inhibits the EGFR tyrosine kinase enzyme, which is responsible for:

Cancer cell growth
Cell division
Tumor spread

By blocking this pathway, it:

Reduces tumor size
Slows disease progression
Improves survival outcomes in EGFR-mutated lung cancer patients

Uses & Treatments

Primary Use

Treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) with EGFR mutation

Other Clinical Uses

First-line therapy in EGFR-positive lung cancer
Patients unsuitable for chemotherapy
Maintenance therapy after initial cancer control

Dosage & Administration

Recommended Dose: 250 mg once daily
Take orally with or without food
Take at the same time every day

Missed Dose

Take as soon as remembered
Skip if close to next dose (do NOT double dose)

⚠️ Always follow oncologist guidance—dosage may vary based on patient condition.

How to Use

Swallow tablet whole with water
Do not crush or chew
Take consistently at the same time
Continue treatment as prescribed

Advantages of Giftinat Gefitinib

Targeted therapy (less damage to healthy cells)
Oral administration (no hospitalization required)
Effective for EGFR mutation-positive patients
Better tolerance than traditional chemotherapy
Helps improve quality of life

Side Effects (Common)

Diarrhea
Skin rash or acne
Dry skin
Nausea

Serious (Rare)

Lung inflammation
Liver toxicity
Severe skin reactions

⚠️ Seek medical help for breathing issues or severe symptoms.

Storage Conditions

Store below 25°C
Keep in a dry place
Protect from moisture and sunlight
Keep out of reach of children

Alternative Brands (Same Composition – Gefitinib 250 mg)

International Brand

Iressa

Indian Brands

Geftinat
Geftib
Geffy
Gefticip
K-Gef
Geftibenz

All these brands contain the same Gefitinib 250 mg composition and are used interchangeably under medical supervision.

Conclusion

Giftinat Gefitinib 250mg Tablet is a highly effective targeted therapy for patients with EGFR-positive non-small cell lung cancer. It offers a convenient oral treatment option with fewer side effects compared to chemotherapy. With multiple affordable Indian alternatives available, it ensures accessibility for patients worldwide.